Abemaciclib Improves PFS at Six Months Among Patients with High-Grade Meningiomas Harbouring NF2 or CDK Pathway Alterations By Ogkologos - January 26, 2026 196 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the Alliance A071401 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Indications for Serplulimab Adding Relacorilant to Nab-paclitaxel Prolongs OS in Patients with Platinum-Resistant Ovarian Cancer Quadruplet Isa-KRd Regimen Improves NGS-MRD Negativity in Transplant-Eligible Patients with Newly Diagnosed Multiple Myeloma MOST POPULAR Molecular Determinants of Sotorasib Efficacy in Patients with Advanced KRASG12C-mutated NSCLC June 6, 2025 For AYAs with Advanced Cancer, Study Finds Serious Communication Gaps about... April 15, 2025 Embrace Your Inner Flexibility March 29, 2021 5-Year-Old Boy Meets Generous Stem Cell Donor Who Cured Him October 13, 2021 Load more HOT NEWS Help Desk for Oncologists Treating People with a Rare Leukemia Pays... WHO’s plans to create a ‘cervical cancer-free future’ “I feel extremely proud when I look at what we’ve achieved”: ScottishPower’s Andrew... 2021 ASCO Annual Meeting: Immunotherapy for Melanoma and Non-Small Cell Lung Cancer,...
